Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2014-002062-77 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Surgery of the anterior cruciate ligament of the knee is frequently a young patient surgery. The post-operative pain of this surgery is managed according to recommendation. In the majority of case, femoral nerve block is performed. The femoral nerve block can cause "paralysis" of the quadriceps more or less complete that no allowing a good quadriceps locking. This locking is indispensable to avoid post-operative flexima and to ensure stabilization of the knee during walking.
In France, the surgery requires a duration of hospitalization from 2 to 4 days in the most cases. It is sometimes performed in ambulatory especially in the USA. But, at the home, pain requires powerful analgesics with their adverse events.
Today, no anesthesic technics for surgery of anterior cruciate ligament of the knee ensure in the same time optimal analgesia and optimal quadriceps locking. The main objective of the investigators study is to compare two analgesia techniques : femoral nerve block vs intra articular injection and obturator nerve block in surgery of the anterior cruciate ligament of the knee
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| femoral nerve block | Active Comparator | 20 ml injection of 2 mg/ml ropivacaine in femoral nerve |
|
| obturator nerve block and intraarticular injection | Experimental | 10 ml injection of 2 mg/ml ropivacaine in obturator nerve intraarticular injection : 10 ml of chlorhydrate ropivacaine (2 mg/ml) and 10ml of magnesium sulfate |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Femoral nerve block | Procedure | 2 mg/ml |
| |
| obturator nerve block |
| Measure | Description | Time Frame |
|---|---|---|
| number of patients with success | success is defined by : score chung > or egal to 9 and quadriceps locking > or egal to 3/5 | 4 postoperative hours |
| Measure | Description | Time Frame |
|---|---|---|
| Pain for all patients | pain measured by EVA | Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48 |
| analgesic consumption for all patients | analgesic consumption of tramadol and morphine (use, number) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sylvie PASSOT, MD | CHU de Saint-Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| PASSOT | Saint-Etienne | 42055 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Procedure |
|
| intraarticular injection | Procedure |
|
| Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48 |
| analgesic adverse events for all patients | Frequency of nausea and vomiting | Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48 |
| ID | Term |
|---|---|
| D007270 | Injections, Intra-Articular |
| ID | Term |
|---|---|
| D007267 | Injections |
| D004333 | Drug Administration Routes |
| D004358 | Drug Therapy |
| D013812 | Therapeutics |
Not provided
Not provided